Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

PA Philip, MR Mahoney, C Allmer, J Thomas… - Journal of Clinical …, 2005 - ascopubs.org
Purpose Epidermal growth factor receptor/human epidermal growth factor receptor 1
(EGFR/HER1) and ligand expression is frequently seen in hepatocellular cancers (HCCs) …
被引用次数：612 相关文章

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

PA Philip, MR Mahoney, C Allmer… - Journal of Clinical …, 2005 - profiles.wustl.edu
Purpose: Epidermal growth factor receptor/human epidermal growth factor receptor 1
(EGFR/HER1) and ligand expression is frequently seen in hepatocellular cancers (HCCs) …

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

PA Philip, MR Mahoney, C Allmer… - Journal of clinical …, 2005 - pubmed.ncbi.nlm.nih.gov
Purpose Epidermal growth factor receptor/human epidermal growth factor receptor 1
(EGFR/HER1) and ligand expression is frequently seen in hepatocellular cancers (HCCs) …

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

PA Philip, MR Mahoney, C Allmer… - Journal of Clinical …, 2005 - mayoclinic.elsevierpure.com
Purpose: Epidermal growth factor receptor/human epidermal growth factor receptor 1
(EGFR/HER1) and ligand expression is frequently seen in hepatocellular cancers (HCCs) …
[PDF] academia.edu

[PDF][PDF] Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer

PA Philip, MR Mahoney, C Allmer, J Thomas, HC Pitot… - J Clin Oncol, 2005 - academia.edu
Purpose Epidermal growth factor receptor/human epidermal growth factor receptor 1
(EGFR/HER1) and ligand expression is frequently seen in hepatocellular cancers (HCCs) …

[引用][C] Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer

PA PHILIP, MR MAHONEY, C ALLMER… - Journal of clinical …, 2005 - pascal-francis.inist.fr
Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer CNRS
Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple search …

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

PA Philip, MR Mahoney, C Allmer… - Journal of Clinical …, 2005 - hsrc.himmelfarb.gwu.edu
Purpose: Epidermal growth factor receptor/human epidermal growth factor receptor 1
(EGFR/HER1) and ligand expression is frequently seen in hepatocellular cancers (HCCs) …

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

PA Philip, MR Mahoney, C Allmer… - Journal of Clinical …, 2005 - pure.johnshopkins.edu
Purpose: Epidermal growth factor receptor/human epidermal growth factor receptor 1
(EGFR/HER1) and ligand expression is frequently seen in hepatocellular cancers (HCCs) …

Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer

PA Philip, MR Mahoney, C Allmer, J Thomas… - Journal of Clinical …, 2005 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Epidermal growth factor
receptor/human epidermal growth factor receptor 1 (EGFR/HER1) and ligand expression is …

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer.

PA Philip, MR Mahoney, C Allmer… - Journal of Clinical …, 2005 - europepmc.org
Purpose Epidermal growth factor receptor/human epidermal growth factor receptor 1
(EGFR/HER1) and ligand expression is frequently seen in hepatocellular cancers (HCCs) …